Skip to main content

Halomon

ADVERTISEMENT
Identification
Molecular formula
C25H33BrO4
CAS number
142979-53-4
IUPAC name
[(3S,5S,10S,13R,14S,17R)-10-formyl-5,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-bromoacetate
State
State

Halomon is found in a liquid state at room temperature.

Melting point (Celsius)
30.00
Melting point (Kelvin)
303.15
Boiling point (Celsius)
315.00
Boiling point (Kelvin)
588.15
General information
Molecular weight
458.36g/mol
Molar mass
458.3610g/mol
Density
1.5660g/cm3
Appearence

Halomon is typically a colorless to yellowish oily liquid.

Comment on solubility

Solubility of [(3S,5S,10S,13R,14S,17R)-10-formyl-5,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-bromoacetate

The solubility of the compound [(3S,5S,10S,13R,14S,17R)-10-formyl-5,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-bromoacetate can be quite intricate due to its complex structure. Several factors influence its solubility:

  • Polarity: The presence of hydroxyl groups generally increases solubility in polar solvents like water, while hydrophobic hydrocarbon portions may impede solubility.
  • Functional Groups: The 2-bromoacetate group may impart some degree of solubility in organic solvents, yet the size and characteristics of the cyclopenta[a]phenanthrene skeleton could present challenges.
  • Hydrogen Bonding: The ability of the molecule to form hydrogen bonds can enhance solubility in appropriate solvents, specifically those capable of donating or accepting hydrogen bonds.

In conclusion, the solubility of such a complex molecule is influenced by:

  1. The balance between hydrophilic and hydrophobic regions
  2. The nature of the solvent
  3. Environmental conditions such as temperature and pressure

Due to these factors, “solubility is often not a simple question”; rather, it requires a nuanced understanding of chemical interactions. Experimental data is typically necessary to ascertain precise solubility properties for compounds of this nature.

Interesting facts

Insights into a Unique Chemical Compound

The compound known as (3S,5S,10S,13R,14S,17R)-10-formyl-5,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl 2-bromoacetate represents a fascinating intersection of organic chemistry and medicinal applications.

Interesting Facts

  • Steroisomerism: This compound showcases multiple stereocenters, indicating its potential for stereoisomerism. Such variations can lead to different biological activities and properties, making stereochemical configuration crucial in drug design.
  • Bioactivity: Compounds related to cyclopenta[a]phenanthrenes are often investigated in pharmacology due to their diverse biological activities, potentially including anti-cancer and anti-inflammatory effects.
  • Functional Groups: The presence of formyl and bromoacetate groups adds reactivity, hinting at potential pathways for further chemical modifications or the development of derivatives with enhanced properties.
  • Natural Product Chemistry: The structure suggests a relationship to natural products, which frequently serve as inspiration for synthetic analogs in the pharmaceutical industry.
  • Complexity of Synthesis: The synthesis of such a compound likely involves intricate multi-step processes, showcasing the ingenuity of organic chemists in creating complex structures with specific functionalities.

This compound encapsulates the intricate beauty of organic chemistry, serving as a reminder of the vast potential within complex organic molecules for medicinal and industrial applications.

Synonyms
Strophanthidin 3-bromoacetate
Strophanthidin bromoacetate
NSC 96738
BRN 0067333
4-18-00-03130 (Beilstein Handbook Reference)
Card-20(22)enolide, 3-((bromoacetyl)oxy)-5,14-dihydroxy-19-oxo-, (3-beta,5-beta)-
5-beta-CARD-20(22)ENOLIDE, 3-beta,5,14-TRIHYDROXY-19-OXO-, 3-(BROMOACETATE)